Risk of adverse outcomes following treatment with direct acting antiviral drugs in HCV infected patients with liver cirrhosis
Introduction: Hepatitis C virus (HCV) is the second major cause of death in Pakistan. Previously, interferon-based regimens were considered highly recommended therapy for HCV patients. Since 2015, interferon-based therapy has been replaced with interferon-free therapy also known as Direct Acting Ant...
Enregistré dans:
| Auteurs principaux: | , , , , , , |
|---|---|
| Format: | Artigo |
| Langue: | Inglês |
| Publié: |
Elsevier
2023-05-01
|
| Collection: | Heliyon |
| Sujets: | |
| Accès en ligne: | http://www.sciencedirect.com/science/article/pii/S2405844023033765 |
| Tags: |
Pas de tags, Soyez le premier à ajouter un tag!
|